New dosing schedule tested to better protect moms from dangerous blood clots
NCT ID NCT04861103
Summary
This study is testing if giving a common blood-thinning medication three times a day, instead of the usual twice a day, keeps drug levels more consistent in pregnant women. The goal is to provide steadier protection against dangerous blood clots, which pregnant women are at higher risk of developing. Researchers will measure anti-clotting activity in about 12 high-risk pregnant women who need this medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY, HIGH-RISK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.